Vir Biotechnology, Inc. (VIR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -132.39M | -25.88M | -167.57M | -120.22M | -78.12M | -87.64M | -171.48M | -77.85M | -109.39M | -107.93M | -155.83M | -389.25M |
| Operating CF Margin % | 456503.45% | -40.39% | -69820.83% | -9902.72% | -2576.39% | -708.22% | -7205.04% | -2531.61% | -194.04% | -642.92% | -5904.85% | -10251.44% |
| Operating CF Growth % | -69.47% | 70.47% | 2.28% | -54.43% | 28.59% | 18.8% | -10.04% | 80% | 13.03% | -407.26% | -232.17% | -140.54% |
| Net Income | -125.69M | -42.92M | -163.14M | -110.96M | -120.97M | -104.59M | -213.72M | -138.38M | -65.28M | -115.97M | -163.41M | -194.78M |
| Depreciation & Amortization | 2.81M | 2.9M | 3M | 9.53M | 2.87M | 2.89M | 2.9M | 4.26M | 4.52M | 4.48M | 6.4M | 6.98M |
| Stock-Based Compensation | 0 | 22.56M | 0 | 12.45M | 14.06M | 15.84M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -2.64M | 57K | -363K | 0 | -1.06M | 0 | 0 |
| Other Non-Cash Items | 13.18M | -5.57M | 13.17M | -6.18M | 0 | 17.87M | 21.79M | 58.99M | 33.52M | 37.38M | 30.87M | 51.43M |
| Working Capital Changes | -22.68M | -2.84M | -20.6M | -25.06M | 26.06M | -17M | 17.49M | -2.35M | -82.15M | -32.75M | -29.69M | -252.88M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | -8.75M | -54K | 2.69M | -401K | -3.61M | 0 | 948K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -4.23M | 2.96M | -5.4M | 8.86M | -1.42M | -1.94M | 3.11M | -2.89M | 735K | 2.63M | -7.53M | -934K |
| Cash from Investing | 11.84M | 86.65M | 40.45M | 56.46M | 126.82M | 140.74M | 118.6M | 211.61M | 28.42M | -104.81M | -58.95M | 230.31M |
| Capital Expenditures | -390K | 4.48M | -317K | -2.54M | -1.63M | -2.41M | -2.36M | -666K | -1.87M | -1.53M | -3.71M | -9.46M |
| CapEx % of Revenue | -1344.83% | 7% | 132.08% | 209.06% | 53.73% | 19.45% | 98.99% | 21.66% | 3.32% | 9.14% | 140.74% | 249.07% |
| Acquisitions | 0 | -37K | 37K | 0 | 0 | 0 | 5K | 379K | 533K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -4.91M | 0 | 45K | 281K | 2.87M | -412K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 162.52M | 1.04M | 102K | 2.05M | 598K | 1.26M | 31K | 2.94M | 152K | 1.68M | 277K | 3.18M |
| Debt Issued (Net) | 0 | -361K | 0 | 0 | 0 | 13K | -40K | -69K | -69K | -87K | -66K | -68K |
| Equity Issued (Net) | 162.52M | 1.04M | 101K | 2.41M | 598K | 1.25M | 71K | 3.01M | 221K | 1.77M | 343K | 3.35M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 359K | 1K | -360K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -100K |
| Net Change in Cash | 41.98M | 61.81M | -127.02M | -61.72M | 49.3M | 54.37M | -52.86M | 136.76M | -80.8M | -210.45M | -214.82M | -155.76M |
| Free Cash Flow | -132.78M | -21.39M | -167.89M | -122.76M | -79.75M | -90.04M | -173.84M | -78.51M | -111.26M | -109.46M | -159.54M | -398.7M |
| FCF Margin % | 457848.28% | -33.39% | -69952.92% | -10111.78% | -2630.11% | -727.67% | -7304.03% | -2553.27% | -197.36% | -652.06% | -6045.59% | -10500.5% |
| FCF Growth % | -66.5% | 76.24% | 3.42% | -56.35% | 28.33% | 17.74% | -8.96% | 80.31% | 16.12% | -585.85% | -261.3% | -142.44% |
| FCF per Share | -0.90 | -0.15 | -1.21 | -0.89 | -0.58 | -0.66 | -1.27 | -0.58 | -0.82 | -0.81 | -1.19 | -2.97 |
| FCF Conversion (FCF/Net Income) | 1.05x | 0.60x | 1.03x | 1.08x | 0.65x | 0.84x | 0.80x | 0.56x | 1.68x | 0.93x | 0.95x | 2.00x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |